These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38435690)

  • 1. Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against
    Bonacorsi A; Trespidi G; Scoffone VC; Irudal S; Barbieri G; Riabova O; Monakhova N; Makarov V; Buroni S
    Front Microbiol; 2024; 15():1357708. PubMed ID: 38435690
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.
    Hwang HJ; Choi H; Hong S; Moon HR; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.
    Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A
    Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic-Potentiating Effect of Some Bioactive Natural Products against Planktonic Cells, Biofilms, and Virulence Factors of
    Chimi LY; Bisso BN; Njateng GSS; Dzoyem JP
    Biomed Res Int; 2023; 2023():9410609. PubMed ID: 37663785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the
    D'Angelo F; Baldelli V; Halliday N; Pantalone P; Polticelli F; Fiscarelli E; Williams P; Visca P; Leoni L; Rampioni G
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musa acuminata and its bioactive metabolite 5-Hydroxymethylfurfural mitigates quorum sensing (las and rhl) mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa in vitro.
    Vijayakumar K; Ramanathan T
    J Ethnopharmacol; 2020 Jan; 246():112242. PubMed ID: 31533077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an
    Harrington NE; Littler JL; Harrison F
    Appl Environ Microbiol; 2022 Feb; 88(3):e0178921. PubMed ID: 34878811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exopolysaccharide-Repressing Small Molecules with Antibiofilm and Antivirulence Activity against Pseudomonas aeruginosa.
    van Tilburg Bernardes E; Charron-Mazenod L; Reading DJ; Reckseidler-Zenteno SL; Lewenza S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
    Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiofilm Activities of Borneol-Citral-Loaded Pickering Emulsions against Pseudomonas aeruginosa and Staphylococcus aureus in Physiologically Relevant Chronic Infection Models.
    Wang W; Bao X; Bové M; Rigole P; Meng X; Su J; Coenye T
    Microbiol Spectr; 2022 Oct; 10(5):e0169622. PubMed ID: 36194139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
    Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
    Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa
    Moustafa DA; Wu AW; Zamora D; Daly SM; Sturge CR; Pybus C; Geller BL; Goldberg JB; Greenberg DE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa.
    Rezzoagli C; Archetti M; Mignot I; Baumgartner M; Kümmerli R
    PLoS Biol; 2020 Aug; 18(8):e3000805. PubMed ID: 32810152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin
    Wang L; Zhang Y; Lin Y; Cao J; Xu C; Chen L; Wang Y; Sun Y; Zheng X; Liu Y; Zhou T
    Microbiol Spectr; 2023 Feb; 11(1):e0199222. PubMed ID: 36475724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against
    Rineh A; Soren O; McEwan T; Ravikumar V; Poh WH; Azamifar F; Naimi-Jamal MR; Cheung CY; Elliott AG; Zuegg J; Blaskovich MAT; Cooper MA; Dolange V; Christodoulides M; Cook GM; Rice SA; Faust SN; Webb JS; Kelso MJ
    ACS Infect Dis; 2020 Jun; 6(6):1460-1479. PubMed ID: 32329596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Antivirulence Activity of Pulverulentone A, a Phloroglucinol-Derivative from
    Ismail MM; Hassan M; Moawad SS; Okba MM; Ashour RM; Fayek NM; Saber FR
    Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.